Delivery Order SPE2DR25D1053-SPE2DR26FT665
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Adapalene 0.1% Cream in 45-gram units, with a ceiling value of $2,134.71 and an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a continuation of the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Adapalene 0.1% Cream in 45-gram units, with a ceiling value of $4,509.24. This is a firm fixed price, non-set-aside competitively awarded contract with an ultimate completion date of August 28, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Adapalene 0.1% Cream in 45-gram units, with a ceiling value of $1,241.06 and a firm fixed price structure. This non-set-aside contract is set for completion by August 15, 2025, and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Adapalene 0.1% Cream in 45-gram units. This is a firm fixed price delivery order with a ceiling value of $1,995.96 and an ultimate completion date of September 30, 2025. The contract carries no set-aside designation and was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will...
- The Defense Logistics Agency awarded a $6,809.55 firm fixed price delivery order to AmerisourceBergen Drug Corp for Adapalene 0.1% Cream in 45-gram quantities, with an ultimate completion date of September 11, 2025. The award, issued on September 10, 2025, carries no set-aside designation and represents a competitively awarded contract. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,693.65 to AmerisourceBergen Drug Corp for the supply of Adapalene 0.1% Cream in 45-gram quantities. This competitively awarded, firm fixed-price delivery order was issued on September 19, 2025, with an ultimate completion date of September 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a $2,933.89 firm fixed price delivery order to AmerisourceBergen Drug Corp for Adapalene 0.1% cream (45 grams) on September 18, 2025, with an ultimate completion date of September 19, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader federal pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,044.76 to AmerisourceBergen Drug Corp for the supply of Adapalene 0.1% cream in 45-gram quantities. This is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, awarded on September 10, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adapalene 0.1% Cream in a 45-gram quantity, with a ceiling value of $1,082.14. This firm fixed-price delivery order, issued on September 15, 2025, with an ultimate completion date of September 16, 2025, represents a child contract under AmerisourceBergen's larger federal contract vehicle. The contract was competitively awarded with no set-aside designation and will be performed at the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Adapalene 0.1% Cream (45GM) on September 22, 2025, with a ceiling value of $1,732.12 and an ultimate completion date of September 23, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation, to be performed at the awardee's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT665Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Adapalene 0.1% Cream in 45-gram units, with a ceiling value of $1,152.06. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 7, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the open competitive procurement process. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a prime pharmaceutical vendor for the Defense Logistics Agency's Medical Supply Chain, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical products to support military and federal healthcare systems worldwide. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical procurement requirements across multiple therapeutic domains, positioning it as a critical vendor for Department of Defense medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 11/6/25 |